Senior insider sale
Chief Executive Officer at CORCEPT THERAPEUTICS INC — senior position signals high conviction
$1.35M
40K shares
What this filing means
BELANOFF JOSEPH K plans to sell 40K shares of CORCEPT THERAPEUTICS INC valued at approximately $1.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/25/2026ACC: 0001973251-26-000010
DirectorOfficer· Chief Executive Officer
Since Feb 2026
40K
Shares to sell
$1.35M
Approx. market value
40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
7/6/2022
40KTotal acquired40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/6/2022 | Stock Option Exercise Cash | 40K | — |
| Total | 40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
40K
Market value
$1.35M
3/25/2026
Total
Units
40K
Value
$1.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/25/2026 | 40K | $1.35M | NASDAQ | Planned |
| Total | 40K | $1.35M | ||